Lv1
90 积分 2024-11-28 加入
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
2小时前
待确认
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
2天前
已完结
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
17天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
17天前
已完结
Surgery or radiation in the treatment of larynx cancer?
1个月前
已关闭
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已完结
Reducing antibiotic use in influenza: challenges and rewards
1个月前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
3个月前
已完结
Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease
4个月前
已完结
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease
4个月前
已完结
皖公网安备34019202002308
